A Review On The Case Of Eli Lilly And Company Versus Canada

If one hold a key to resolve a very serious problem, one has a responsibility to put an effort to make it happen, at least try one’s best. In this case, river blindness disease was a very serious problem, and Dr. Vagelos was the one who could make a decision as to whether the research and development of a human version of ivermectin should be carried on, then it was his responsibility to pursue it.

The current system is inefficient, inequitable and unsustainable in the long run because: (1) it is unable to accommodate for the entire Canadian population; (2) it requires Canadians to pay a disproportionate amount of their income to access medications; and (3) governments are unable to contain the drug cost increases (5). Therefore two recommended reforms are described in order to achieve the goal of accessibility and equity.

People today are blinded by the clouds of drugs. Just within the 2015 year over, 47 thousand Canadians deaths were linked to substance abuse. Canadians are aware of the dangers connected to taking part in this practice, however, we do not want to accept it.

Corporations and business organizations have to face lawsuits due to breach of different laws i.e., consumers laws, copyright laws, compensation laws, security laws, antitrust, employment or environmental laws. For violating any of these laws companies have to pay fines and even go bankrupt. Current paper is a report on one such lawsuit that caused GlaxoSmithKline loss of billions of dollars. The author selected "Avandia Lawsuit" to focus in this report. Avandia is a drug used to treat type 2 diabetes and was prepared by GlaxoSmithKline which was approved by U.S Government in 1998 and became best selling drug. Company generated profit through its sale but soon complains arose due to increasing incidences of heart disease and stroke as side effect of the drug.

Value: Angiomax is a blood-thinning drug, or anticoagulant, used in emergency coronary heart care. Angiomax is positioned as an alternative to heparin, the most commonly used anticoagulant in emergency coronary heart care, so to assess Angiomax value to a hospital is required to compare these two drugs.

The widespread use of synthetic drugs in Canada is becoming increasingly concerning, particularly in BC and Alberta, where overdoses have been far too common in recent years, with eight deaths related to contaminated ecstasy occurring in a two year span in Alberta alone (Hudson et al., 2014). After several tragic fatalities from ecstasy, the RCMP in Alberta and British Columbia started a successful public awareness initiative which informed the public about the dangers of using ecstasy (Hudson et al., 2014). The extensive media coverage and constant warnings from the RCMP about contaminated ecstasy may have caused users to change to different legal highs where the substances are deemed to be pure, but not for human use, thus evading

If a company is found to be non-guilty in a court of law, does it mean that the company made sound business decisions, or simply that they didn’t break any laws that are written in black and white? Merck, the producer of an anti-inflammatory drug Vioxx, knowingly sold and continued to market the drug on a large scale even though it was found to carry substantial risks to cardiovascular health. Additionally, even after external research, product labels failed to effectively communicate the increased risk of heart attacks or cardiac death. Although Merck was not proven, in the eyes of the law, to have known the extent of harmful side effects before they pulled the drug, there are several indications that they did have enough information to discontinue the drug pending further research. The questionable decisions made by the company caused thousands of patients who were prescribed the medication to suffer heart attacks, or even die.

The United States Patent and Trademark Office is overloaded with thousands of applications a year, given an applicant can even get their patent filed. In the pharmaceutical industry, the patent process is in dire need of being reformed. A typical patent last twenty years and the process is a little different when it comes to manufacturing drugs compared to other industries. Partly because in the medical field research is more or less openly shared. However, on the pharmaceutical side the more concealed the better the chances are to get good profitable returns. During the beginning stages of getting a drug to market the drug must be tested and adhere to the Food and Drug Administration’s (FDA) guidelines. An FDA approved drug means that the

Johnson & Johnson could take more money and experiment more on their products. They need to avoid any lawsuits. They do not need no more recalls or negativity towards their name. They need to spend more money testing on their products before releasing them. On the safe side, they can use people for experiments, pay them, and sign legal rights to avoid lawsuits. They will be fine if they stick to deontology theory by obligating their consumer with nothing but safe products. They stick to benefit more people they will be using the utilitarianism theory. They will be gaining their charter back with all these great things, so virtue will come in the picture. They main focus should be making sure them bringing out great quality safe products or

MedTech Pharmaceutical is not meeting its full potential in sales. Some changes would need to be considered to help encourage salespeople to perform better. Even though they are working off full commission, other incentives need to be implemented. Morale needs to be high in order to reach the potential. Encouragement for advances needs to be visible to the salespeople so they do not become complacent. Therefore, changes could help the organization grow and reach their potential.

In conclusion, there have been economic and political factors that have contributed to national, and international levels which resulted in pressure in the private and public healthcare system. Pharmaceutical companies intend for financial gain for the shareholders and developers to create the largest markets in the industry. Developers promote expensive drugs to shareholders and industries to increase profit. The cost of prescription has stabilized the types of drugs that would increase. Pharmaceutical industry collaborates with doctors to promote their medicines and prescribe their patients. However, there have been several factors affecting drug expenditures in Canada.

From 2004 to 2012, the quantity of remote direct ventures has expanded more than the double, achieving USD 1,500 billion of every 2012. FDI has turned out to be one of the significant techniques for cross-outskirt venture and a standout amongst the most dynamic drivers of monetary development. Presently, I will propose a portion of the dangers of FID from the perspective of

Another important topic of the negotiations are the reduction of non-tariff barriers and the harmonization of regulatory measures in order to move towards a more integrated transatlantic marketplace (HLWG 2013, p. 3). Despite of the high level of openness concerning trade, Appendix 1 and 2 show that trade partnership between EU and US has been worsening compared to other areas of the World. There exist still different barriers to trade and investments that block the economic potential of such an agreement; indeed 46% of TTIP stakeholders consider unnecessary regulatory barriers as an obstacle to trade, 45% tariffs, 38% customs procedures and 20% barriers to investment (European Commission 2013a, p. 12).

In this assignment I am discussing some case study questions from chapter 7 and critical thinking discussion questions for chapters 8 and 9 of the Global Business Today text. These questions are for the individual week 3 assignment of our MBA 539 International Business class. These discussion questions are composed to increase the reader’s understanding of “the political economy of international trade”, “foreign direct investment” and “regional economic integration” as explained within Global Business Today (Hill, C., 2014).

Modern communications infrastructure makes it possible for anyone with a bank account to make a “foreign portfolio investment” (FPI). Rich and poor alike can gain from this ability to trade stocks and bonds overseas with speed and ease. For those with sufficient resources, however, a “foreign direct investment” (FDI) can also be made. While both types of investment can be lucrative for the investor, I believe that foreign direct investments are usually better for the country receiving the investment, and so FDIs should be the favored form of investment for those with the means to make them.